Johnson & Johnson acquires lung cancerfocused robotics firm Auris Health in potential $5.75m deal httpbit.ly2S2jtPr JNJCares JNJNews pharma cancer .

Johnson & Johnson acquires lung cancer-focused robotics firm Auris Health in potential $5.75m deal http://bit.ly/2S2jtPr  @JNJCares @JNJNews #pharma #cancer .

12:30 EST 14 Feb 2019 | Pharmafile

Johnson & Johnson acquires lung cancer-focused robotics firm Auris Health in potential $5.75m deal http://bit.ly/2S2jtPr  @JNJCares @JNJNews #pharma #cancer .

More From BioPortfolio on "Johnson & Johnson acquires lung cancer-focused robotics firm Auris Health in potential $5.75m deal http://bit.ly/2S2jtPr  @JNJCares @JNJNews #pharma #cancer ."